at present , mupirocin ( 2 percent ) ointment has been approved for use in the treatment of impetigo , but an analysis of several recent clinical trials has also indicated the potential for mupirocin treatment of other primary and secondary skin infections .
C0085259
mupirocin
C0021099
impetigo